Targeting BTK in CLL: Beyond Ibrutinib

Overview of attention for article published in Current Hematologic Malignancy Reports, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 432)
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 1 news outlet
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 98 Dimensions

Readers on

mendeley: 124 Mendeley

Summary News Patents Facebook Dimensions citations

So far, Altmetric has seen 1 news story.

Bruton Tyrosine Kinase Inhibitors in B-Cell Lymphomas

OncLive, 30 Sep 2020

Bruton tyrosine kinase (BTK) inhibitors play an important role in the therapeutic spectrum of B-cell lymphomas.